Le Lézard
Classified in: Health, Science and technology

Trella Health Enhances Marketscape Insights for HME and Infusion Organizations with the Addition of Claim and Patient Counts


HME and Infusion organizations can maximize growth potential and strategically target top referral sources by leveraging patient and claim counts.

ATLANTA, April 25, 2024 /PRNewswire/ -- Trella Health, the leader in HME and Infusion growth and productivity solutions, announces the recent release of claim and patient counts within its Marketscape Insights platform.

"The patient and claim counts in the Marketscape Insights solution play a valuable part in our growth strategy."

This highly requested insights feature provides HME and Infusion organizations with greater visibility into their market. 

Previously, organizations were limited to decile rankings, which offered directional insight into volume. For instance, while a ranking of 10 might signify the highest tier, the actual claim count could vary significantly across different code sets ? from 25 claims to 500 claims.

Now, organizations can gain a more detailed understanding of claim volume for more informed decision-making.

Tyler Rardin, GM of HME and Infusion Markets at Trella Health stated, "At Trella, our goal is to consistently innovate to provide our customers with the greatest visibility into the market, to support them in maximizing their efficiencies and focus on the areas that align with their strategy. We are thrilled to have released visibility into Physician and Organization patient and claim counts within the Marketscape Insights for HME and Infusion platform. With these insights, customers gain an even deeper understanding on the size on Physician and Organization relationships, allowing them to make more informed decisions on who to partner with. Our dedicated teams continue to innovate to give our customers the tools and knowledge needed to thrive and excel in their markets."

With this recent addition, Business Development Managers and Sales Managers can guide their teams to prioritize efforts on high-value partnerships, avoiding wasted resources on referrals that may not be a good fit for their sales strategy be a good fit.

Codes are billed at different frequencies, making reliance on claim counts alone insufficient.

With the patient count integration of Medicare FFS, MA, Medicaid, and Commercial insurances ? organizations gain a more accurate picture of patient volume and associated claims by payer.

This is particularly crucial for sales teams whose commissions are tied to acquiring new patients.

Below are a few ways sales teams can gain additional visibility into the size of physician and organization relationships:

"The patient and claim counts in the Marketscape Insights solution play a valuable part in our growth strategy. With this data, our representatives are able to focus their efforts with greater effect." stated Joe Consedine, Director of Marketing at Martin Bionics Prosthetics + Research.

At Trella, we are committed to consistent innovation to empower our customers with invaluable market insights to thrive in their markets. We look forward to seeing how these innovations continue to support our customers and help them achieve their strategic goals.

About Trella Health
Trella Health's unmatched market intelligence and purpose-built CRM allow post-acute providers and HME and Infusion organizations to drive more effective performance and growth. Trella's solutions allow post-acute, HME, and Infusion organizations to identify the highest-potential referral targets, evaluate new market opportunities, and monitor performance metrics. Paired with CRM and EHR integrations, business development teams can better manage referral relationships to advance their organizations with certainty by improving their sales and marketing strategy.

For more information on Trella Health and its HME and Infusion growth solutions, visit www.trellahealth.com, call 678-813-1590, or follow Trella on Facebook, Twitter, and LinkedIn.

Media Contact: Lauren Corcoran, [email protected]

SOURCE Trella Health


These press releases may also interest you

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

4 mai 2024
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

4 mai 2024
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: